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Abstract 
Background: Cartilage-hair hypoplasia (CHH) is a rare skeletal dysplasia characterized by disproportionate short 
stature, immunodeficiency, anemia and risk of malignancies. All these features can affect pregnancy and predispose 
to maternal and fetal complications. This study aimed to evaluate obstetric history and maternal and fetal outcomes 
in women with CHH.
Methods: Among 47 Finnish women with CHH, we identified 14 women with ICD codes related to pregnancies, 
childbirth and puerperium in the National Hospital Discharge Registry and obtained detailed data on gynecologic 
and obstetric history with a questionnaire. Offspring birth length and weight were collected and compared with 
population-based normal values.
Results: There were altogether 42 pregnancies in 14 women (median height 124 cm, range 105–139 cm; 4′1′′, range 
3′5′′–4′7′’). Twenty-six pregnancies (62%), including one twin pregnancy, led to a delivery. Miscarriages, induced abor-
tions and ectopic pregnancies complicated 9, 5, and 2 pregnancies, respectively. Severe pregnancy-related complica-
tions were rare. All women with CHH delivered by cesarean section, mostly due to evident cephalo-pelvic dispropor-
tion, and in 25/26 cases at full-term. In the majority, the birth length (median 48 cm, range 45.5–50 cm; 1′7′′, range 
1′6′′–1′8′′) and weight (3010 g, range 2100–3320 g; 6.6 lb, range 4.6–7.3 lb) of the offspring in full-term singleton 
pregnancies was normal.
Conclusions: Despite CHH mothers’ significant short stature and other potential CHH-related effects on preg-
nancy outcome, most pregnancies lead to a term cesarean section delivery. Since fetal growth was generally unaf-
fected, cephalo-pelvic disproportion was evident and planned cesarean section should be contemplated in term 
pregnancies.
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Background
Bone dysplasia, small maternal height and dispropor-
tion can all affect fertility and natural course of preg-
nancy, and may predispose to pregnancy and obstetric 
complications affecting perinatal outcomes. Women with 
short stature may suffer from respiratory distress during 
pregnancy and experience more cephalo-pelvic dispro-
portion (CPD) leading to high rate of cesarean deliveries 
(CS) [1, 2].
Some studies have previously been performed on 
maternal and fetal outcome in different bone dysplasias. 
Pregnancies in patients with osteogenesis imperfecta 
can be complicated with antepartum hemorrhage, pla-
centa abruption, intrauterine growth restriction (IUGR) 
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and the birth of small-for-gestational-age infants [3]. 
Pregnancy-related complications in women with achon-
droplasia are uncommon, the most serious complica-
tions being worsening of spinal claudication symptoms 
and respiratory failure. Most women with achondropla-
sia have term pregnancies, but planned CS is required 
because of CPD [4]. However, most obstetric reports in 
patients with short stature due to skeletal dysplasia are 
case reports and have mainly focused on anesthetic plan-
ning and performance of cesarean delivery [5, 6].
Cartilage-hair hypoplasia (CHH) is a rare autosomal 
recessive disorder with an incidence of 1: 23,000 live 
births in Finland [7]. It is characterized by short stat-
ure, hypoplastic hair, combined immunodeficiency and 
increased risk for malignancies, especially lymphoma. 
CHH is caused by variants in the RMRP gene, encoding 
the RNA subunit of the mitochondrial RNA processing 
endonuclease, which is involved in cell cycle regulation 
[8]. CHH is a disease with significant variability in phe-
notypic presentation [9]. Women with CHH have adult 
height in the range of 110–140  cm (3′7′′–4′7′′), median 
height being 122.5 cm (4′0′′) [10].
Disproportionate short stature and immunodeficiency 
are among the most prominent features of CHH and can 
adversely influence female patients’ reproductive health. 
Immunodeficiency can predispose pregnant women to 
infections during naturally immunocompromised state in 
pregnancy. In addition to maternal complications, short 
stature might affect fetal growth and predispose to pre-
term deliveries. Despite the growing knowledge of dis-
ease mechanism, many clinical aspects of CHH remain 
uncharacterized. Only limited data are available regard-
ing puberty, reproduction, and gynecologic health in 
patients with CHH [11–13]. The obstetrical literature in 
CHH is limited to case reports [14, 15].
The knowledge gaps in reproductive and obstetric out-
comes are a significant source of concern for patients and 
families affected by CHH. Lack of knowledge may affect 
CHH patients’ family planning. The possibility of obstet-
ric complications can lead medical personnel to discour-
age the patient from becoming pregnant.
The purpose of this study was to evaluate the incidence 
and course of pregnancies and maternal and perinatal 
outcomes in the Finnish cohort of women with CHH.
Patients and methods
Patients
Patients were identified from the Finnish Skeletal Dys-
plasia Registry which includes > 110 living patients with 
genetically confirmed CHH; 56 of them were women 
aged over 18 years. Altogether 47 of these women were 
participants in our ongoing research program on CHH. 
Their ICD-10 codes related to pregnancies, childbirth 
and puerperium (O00*-O99*) were searched from the 
National Hospital Discharge Registry (HILMO). Of the 
47 women with CHH, 19 had pregnancy or delivery-
related diagnoses in the Registry, involving a total of 57 
pregnancies. These 19 women were subsequently invited 
to participate in a questionnaire study of gynecologic and 
obstetric history; 14 consented. Thus, our final study pop-
ulation included 14 CHH women with 42 pregnancies.
Methods
All 14 patients were either interviewed by one of the 
authors (EH) for data regarding reproductive and obstet-
ric history (n = 10) or they provided the information 
using a specific questionnaire (n = 4). The interview and 
questionnaire covered pregnancy-related issues such 
as the number and outcome of pregnancies, pregnancy 
complications, pregnancy weeks (pw) at delivery, mode 
of delivery, delivery and post-partum complications and 
birth weight (BW), birth length (BL) and Apgar score of 
the newborns. Medical records of maternal outcomes 
were reviewed for all women, whereas offspring’s medical 
records were obtained only with a separate permission 
given by 9 of the 14 women and involving 19 children.
BWs and BLs of the offspring were compared with the 
Finnish growth references [16] and transformed into 
Z-scores for all newborns. We excluded from further 
growth analysis a pair of twins and one child born prema-
turely at 25 pw with IUGR.
An ethical approval was obtained from the Research 
Ethics Committee of the Hospital District of Helsinki and 
Uusimaa (HUS/836/2018 Institutional Research Ethics 
Committee).
Mutation analysis
All RMRP mutations had been detected by Sanger 
sequencing either at Laboratory HUSLAB, Finland, or 
as a part of previous or ongoing research at Folkhälsan 
Institute of Genetics, Helsinki [17, 18].
Results
Cohort characteristics
The study cohort consisted of 14 CHH women with 42 
pregnancies (Table  1). At data collection, the median 
age of the cohort was 45.0  years (range 31–72 years). 
All patients had genetically confirmed RMRP mutation 
NR_003051.3: n.71A > G in either homozygous (n = 11) 
or compound heterozygous (n = 3) state. The median 
height of the cohort was 124  cm, range 105–139  cm 
(4′1′′, range 3′5′′–4′7′′).
According to the clinical categorization of immuno-
deficiency in CHH, 6/14 females had clinical symptoms 
of immunodeficiency in adulthood, mostly recurrent 
rhinosinusitis. Three of the six were classified as having 
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clinical combined immunodeficiency because of oppor-
tunistic infections like severe herpes virus infections or 
recalcitrant warts [19].
Miscarriages, ectopic pregnancies and induced abortions
Miscarriages (n = 9) were reported by 7 women. Eight 
miscarriages occurred during first trimester. None of 
the women had recurrent miscarriage, defined as loss of 
three or more consecutive pregnancies. Ectopic pregnan-
cies occurred in two women. However, 89% (8/9) had 
also a successful pregnancy leading to a delivery.
Five induced abortions were reported in four women. 
Three were induced because of social indications and two 
because of fetal indications other than CHH.
Deliveries
A total of 27 live births, including one pair of twins, 
were reported in 12 women. Maternal characteristics in 
pregnancies leading to delivery are presented in Table 2. 
Median maternal age at delivery was 32  years (range 
24–45 years). Twenty-six (96%) of the children were born 
at full-term (pw 37 + 0—41 + 6). One preterm delivery 
due to fetal indication at pw 25 was reported.
All infants were delivered by CS. Two trials of vaginal 
labor, one induced and one spontaneous, were converted 
to CS, one of them complicated by chorioamnionitis. 
Indications for CS are presented in Table 3. Malpresenta-
tion was reported in six cases: fetus was either in breech 
or occiput posterior presentation in four and two cases, 
respectively. Two women had had two CSs, and three 
and two women had had three and four CSs, respectively. 
In four CSs, delivery of the baby was difficult and in two 
cases vacuum-extraction was required also in CS. Suc-
cessful epidural anesthesia was difficult to accomplish 
potentially due to disproportionate spinal anatomy in 
3/25 women and they reported intraoperative pain.
Maternal complications during pregnancy
Ten of the 12 women with a history of delivery (83%) 
reported one or several pregnancy-related complica-
tions (Table  4). Most of the complications were spo-
radic and did not require hospitalization. There was no 
severe maternal morbidity. Despite underlying immuno-
deficiency and increased susceptibility to infections, no 
infections requiring hospitalization during pregnancy 
were reported. Anemia was reported in four pregnancies 
(15%) but none of them required blood transfusions or 
hospitalization. Two cases of placental insufficiency lead-
ing to fetal distress were diagnosed (2/27, 7%) based on 
elevated resistance or retrograde flow of a. umbilicalis 
and IUGR or fetal heart rate abnormalities and IUGR. No 
other placenta-related maternal complications, includ-
ing severe pre-eclampsia or placental abruption, were 
reported.
Offspring’s birth characteristics
Birth measurements were assessed in 19 offspring for 
nine women. We calculated Z-scores for BL and BW 
based on Finnish references for healthy children. We 
excluded a pair of twins and one child born prematurely 
Table 1 Type of 42 pregnancies in 14 women with CHH
a pw, pregnancy weeks
b Combined data from all miscarriages
c Combined data from all pregnancies leading to delivery
Type of pregnancy N (% of all 42 
pregnancies)
Maternal 
age 
(median)
Maternal 
age 
(range)
Early miscarriage (< 12  pwa) 8 (19) 34b 23-40b
Late miscarriage (< 22 pw) 1 (2)
Ectopic pregnancy 2 (5) 34.5 34–35
Induced abortion 5 (12) 36 23–39
Term delivery (37–42 
pw) including one twin 
delivery
25 (60) 32c 24-45c
Preterm delivery (< 37 pw) 1 (2)
Table 2 Maternal characteristics (n = 12) in 26 pregnancies 
leading to delivery
a Data available from 21 pregnancies
b Data available from 16 pregnancies
Characteristics Median Range
Age (years) 32 24–45
Height (cm / ft-inch) 124; 4′11′ 105–139; 3′5′’–4′7′
BMI before pregnancy (kg/m2)a 33.5 29.4–59
Weight gain during pregnancy (kg; lb)b 8.4; 18.5 2.7–12.6; 5.6–27.8
Table 3 Indication and  type of  cesarean section in  26 
deliveries
a CS cesarean section
b CPD cephalo-pelvic disproportion
c In two cases vacuum extraction required
d IUGR intrauterine growth restriction
Indication for  CSa N Type of CS planned/emergency
CPDb,c 9 (1 Emergency, 8 planned)
Previous CS 9 Planned
CPD and previous CS 4 Planned
Twin pregnancy and precious CS 1 Planned
Unsuccessful labor induction and 
IUGR d
1 Emergency
IUGR and asphyxia 1 Emergency
Arrest of labor and fetal position 1 Emergency
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(at 25 pw) from further analysis. In the remaining neo-
nates (n = 16), both BL and BW were in the majority 
below the normal mean (for BL median Z-score − 0.4, 
for BW median Z-score − 0.6) (Table 5). However, both 
measurements remained within the normal distribu-
tion (Z-score > − 2.0), except for one newborn whose BL 
Z-score was -2.4 and BW Z-score -3.3.
Discussion
Pregnant women with skeletal dysplasia are at an 
increased risk of maternal and perinatal morbidity and 
mortality [1, 2, 20]. Recently, a multidisciplinary, inter-
national, consensus-based best practice guideline was 
provided as a minimum standard of care to minimize 
associated health risks, and to improve outcomes for 
pregnant women with skeletal dysplasia [21]. The guide-
lines concluded, that the increased risks of pregnancy in 
these situations are related to multiple factors such as 
cardiopulmonary and musculoskeletal factors in preg-
nant women. However, all skeletal dysplasias have their 
own specific features which may affect fertility and 
obstetric prognosis. Consequently, detailed data on preg-
nancies in different skeletal dysplasias is warranted.
Our study evaluated pregnancy outcomes in women 
with CHH from a unique Finnish cohort including 56 
women with genetically confirmed CHH. We were able 
to review a total of 42 pregnancies in 14 women, 26 of 
which led to delivery. Typical manifestations of CHH, 
including severe short stature and immunodeficiency, 
may have negative impact on fertility and reproduction. 
However, gynecologic and obstetric problems in patients 
with CHH have received only scant attention. We have 
previously published reports on diversity of pubertal 
development and gynecologic health in CHH [11–13]. 
To the best of our knowledge, no comprehensive obstet-
ric reports have ever been published, and the very lim-
ited data on pregnancies in CHH are based on single case 
reports [14, 15]. This is thus the first study to evaluate 
reproductive and obstetric outcomes in a larger cohort of 
women with CHH.
The miscarriage rate in our cohort was 21%, which is 
not increased compared with rates in the general popu-
lation (15–25%) [22]. All but one miscarriage occurred 
during the first trimester. Moreover, 86% (6/7) of women 
with one or two miscarriages, also had a successful preg-
nancy and delivery reflecting positive obstetric prog-
nosis. Thus, CHH does not seem to predispose affected 
women to recurrent miscarriage.
The total number of induced abortions, (12%, 5/42) did 
not differ from the data for the general population, as 
reported in the Finnish national pregnancy termination 
registry [23]. According to the national data, 93% of preg-
nancy terminations in Finland are performed because of 
social indications (unplanned pregnancies), compared to 
only 3.4% for fetal abnormality [23]. In our CHH popula-
tion, a social indication was reported in 60% (3/5) of the 
terminations while 40% (2/5) were due to fetal indica-
tions. The number of unplanned, terminated pregnancies 
was thus not increased among the women with CHH. 
However, the small number of induced abortions does no 
allow any solid conclusions.
Most of the pregnancies leading to a delivery were 
full-term. Preterm birth is defined as delivery under 37 
completed weeks of gestation. In 2013, in the United 
States, 11.4% of all babies were born preterm [24]. In 
Finland in 2018, 5.8% of babies were born under 37 ges-
tational weeks [25]. In our cohort, 96% of babies were 
born fullterm, and there was only one early preterm birth 
(pw 25; 1/27 baby born, 3.7%). We did not observe any 
increase in the rate of complications, such as pregnancy-
related hypertensive disorders or gestational diabetes, as 
Table 4 Maternal disorders predominantly related 
to pregnancy in 26 pregnancies leading to delivery
a Macrocytic anemia in 3 cases, iron deficiency 1 case; none required blood cell 
transfusions
b Blood pressure (BP) > 140/90 mmHg or systolic BP increase > 30 mmHg or 
diastolic BP increase > 15 mmHg during pregnancy
c Diet or insulin controlled
N % of 26 
pregnancies
Maternal disorders related to pregnancy
 Anemiaa 4 15
 Hypertensionb 3 12
 Gestational  diabetesc 3 12
 Placental insufficiency 2 8
 Ischial pain 1 4
 Chorioamnionitis 1 4
 Subjective respiratory distress (3rd trimester) 1 4
 First-trimester bleeding 1 4
 Hyperemesis 1 4
Post partum complications
 Cesarean section wound infection 1 4
 Other post-partum infection 2 8
Table 5 Offspring’s birth characteristics (n = 16)
One pair of twins and one preterm baby were excluded from the analysis
Characteristic Median Range
Pregnancy week 38 + 4 37 + 2—41 + 3
Birth weight (g, lb) 3010; 6.64 2100–3320; 4.63–7.32
Birth weight Z-score − 0.6 − 3.3 − 0.0
Birth length (cm, ft-inch) 48; 1′7′′ 45.5–50; 1′6′′–1′8′′
Birth length (Z-score) − 0.4 − 2.4—+ 0.7
Apgar score (5 min) 9 4–10
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compared with the general Finnish and Nordic popula-
tion [26, 27]. Maternal BMI was increased before preg-
nancy and an average weight gain during pregnancy 
was 8.4 kg (18.5 lb). However, according to best-practice 
guidelines, BMI does not take into consideration body 
proportions in skeletal dysplasia, and there are no evi-
dence-based recommendations concerning gestational 
weight gain. A reasonable approximation in short stature 
women with bone dysplasia is to recommend weight gain 
in the lowest range, a total of 5–9 kg (11–19.8 lb) over the 
course of pregnancy [21].
Since the growth of offspring is not generally affected 
in a recessively inherited disease, normal size of the 
fetus’ head in a smaller maternal pelvis can cause CPD 
and result in dystocia. Moreover, breech presenta-
tion and malpresentations might be more common in 
women with short stature. In our study all subjects had 
a CS, and seven women had recurrent CSs. Recurrent 
CSs increase the risk for placental abruption, placenta-
tion disturbances and post-partum hemorrhage [27]. In 
our series such complications in women with recurrent 
CS were not reported. However, a vacuum extraction was 
required due to CPD and malpresentation twice even in 
planned CS, highlighting the importance of preparation 
for intrapartum complications.
The main limitation of this study is the retrospective 
study design. Number and type of pregnancies and diag-
noses during pregnancies were confirmed from national 
registry. However, information about various subjec-
tive symptoms during pregnancy were mainly based on 
patient interviews and questionnaires. The reliance of 
self-reported data is subjected to recall bias. This study 
is by far the largest series reporting outcome of pregnan-
cies in women with CHH. However, as only 14 women 
altogether were included, the small sample size needs to 
be acknowledged as a limitation, unavoidable in rare dis-
eases. Phenotypic differences in CHH are wide. Severely 
affected patients may not try to conceive, they may not 
conceive spontaneously, or they may not want to partici-
pate in the study, and among them obstetric prognosis 
might be poorer than in this study population. Although 
we did not systematically collect data on the use of 
assisted reproductive treatments from the patients, we 
are aware that these treatments have been used in some 
instances.
Fertility and reproduction are very important factors 
in young women’s life. Decision about subjective willing-
ness and capability of carrying a pregnancy should be 
based on patient´s right to get all potential information 
preconceptionally. According to best-practice guidelines, 
preconceptional medical evaluation is recommended 
to all women with skeletal dysplasia, to consider factors 
that may impact safety of pregnancy, mode of delivery, 
and anesthetic management [21]. Due to rarity of skeletal 
dysplasias, pregnancies need to be assessed and managed 
in facilities that are aware of the potential complications, 
and have the skills and resources to anticipate and man-
age them effectively [21]. Anesthetic assessment should 
be carried out early in the third trimester because of 
challenges in anesthetic management and the risk of an 
emergency CS.
Conclusions
In conclusion, our study on pregnancies and deliveries 
in CHH shows encouraging results and indicates that 
women with CHH, even with remarkable growth restric-
tion, can successfully conceive and complete a normal 
pregnancy until term delivery. Despite underlying immu-
nodeficiency and increased susceptibility to infections, 
no infections requiring hospitalization during pregnancy 
were reported. Because of potential fetal and maternal 
risks, pregnancies and deliveries in women with CHH 
warrant careful advance planning and preparing. Further 
studies, preferably in an international study setting, are 
needed to further elucidate pregnancy and delivery out-
comes in CHH and other rare skeletal dysplasias.
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